Jay Nutt, M.D. is internationally recognized for research on testing novel therapeutics, including neuroprotective and neurorestorative therapies, and gait and balance problems of Parkinson’s; his research on the pharmacokinetics of levodopa has provided significant clinical and scientific insights on this important therapy.

He is currently researching:

Whether a medication originally designed for dementia improves balance and gait in people with Parkinson’s disease Whether gene therapy improves the response to levodopa (Sinemet) in collaboration with University of California San Francisco